Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza subunit vaccine in healthy subjects ≥6 months
CTR20131614Phase 3Completed
- Sponsor
- Dalian Yalifeng Biopharmaceutical
- Start
- Dec 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza virus subunit vaccine in influenza, sponsored by Dalian Yalifeng Biopharmaceutical. Started Dec 2015; status: completed.
02
Drugs
influenza virus subunit vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20131614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131614.